Daniel Spiegelman

2020

In 2020, Daniel Spiegelman earned a total compensation of $2.3M as Former Executive Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 56% decrease compared to previous year.

Compensation breakdown

Salary$449,519
Other$1,860,457
Total$2,309,976

Spiegelman received $1.9M in other compensation, accounting for 81% of the total pay in 2020.

Spiegelman also received $449.5K in salary.

Rankings

In 2020, Daniel Spiegelman's compensation ranked 4,895th out of 13,090 executives tracked by ExecPay. In other words, Spiegelman earned more than 62.6% of executives.

ClassificationRankingPercentile
All
4,895
out of 13,090
63rd
Division
Manufacturing
1,989
out of 5,621
65th
Major group
Chemicals And Allied Products
789
out of 2,254
65th
Industry group
Drugs
680
out of 1,954
65th
Industry
Pharmaceutical Preparations
511
out of 1,459
65th

Pay ratio

Daniel Spiegelman's Pay$2,309,976
Median Employee's Pay$181,141
Pay Ratio

13

to 1

In 2020, the annual total compensation of Daniel Spiegelman was $2,309,976.

The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.

The ratio of Daniel Spiegelman's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 13, 2021.

Spiegelman's colleagues

We found six more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2020.

2020

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2020

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2020

C Guyer

BioMarin Pharmaceutical

Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations

2020

Brian Mueller

BioMarin Pharmaceutical

Chief Financial Officer

2020

Robert Baffi

BioMarin Pharmaceutical

Former President of Global Manufacturing and Technical Operations

2020

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

News

You may also like